medigraphic.com
ISSN 2007-4360 (Print)
Asociación Mexicana de Periodontología, Colegio de Periodoncistas A.C

2022, Number 1-3

<< Back

Rev Mex Periodontol 2022; 13 (1-3)

Ozone therapy as an alternative method in the treatment of bullous pemphigoid: clinical case report

Peralta ER, Valera GE, Coronado PD, Cuevas GJC, Guzmán GDA, Espinosa CLF, García CAG, Castellanos VRO, Donohue CA, Tovar CKL

Language: Spanish
References: 21
Page: 43-47
PDF size: 309.84 Kb.


ABSTRACT

Introduction: bullous pemphigoid is a systemic disorder that causes ruptures on the epithelium tissue due to the formation of subepithelial blisters of autoimmune origin that can be presented in different parts of the body including the oral mucosa and usually have an affinity for the female sex. There are different treatments for bullous pemphigoid, among them corticosteroid-based therapy has shown the best results, however, there are still patients whom this option does not provide the expected results, therefore the search for treatments that can provide an alternative continues. Case description: the objective of this work is to show the effect of ozone-based therapy in a case of bullous pemphigoid with favorable results. The treatment consisted of performing a therapy using ozonated water mouthwashes. The results of the treatment shown a clinical improvement of the patient and the relief of symptoms in each of the subsequent clinical appointments which suggests an efficacy of the use of ozonated water for the treatment of bullous pemphigoid lesions. Conclusion: the use of ozone therapy appears to have an adequate potential for the treatment of bullous pemphigoid. However, future research on this topic will be important for its application in possible treatments.


REFERENCES

  1. Ariyawardana A, Johnson N. Nonneoplastic diseases and disorders of the oral mucosa: A contemporary overview. Periodontol 2000. 2019; 80 (1): 7-11.

  2. Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS et al. A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018; 45 Suppl 20: S1-S8.

  3. Bieber K, Ernst A, Tukaj S, Holtsche M, Schmidt E, Zillikens D et al. Analysis of serum markers of cellular immune activation in patients with bullous pemphigoid. Exp Dermatol. 2017; 26 (12): 1248-1252.

  4. Pulido N, Ángulo D. Penfigoide ampolloso localizado, secundario a trauma en adulto joven: a propósito de un caso. Dermatología CMQ. 2012; 10 (4): 276-278.

  5. Cabanillas J, Guerra C. Penfigoide Ampolloso. Dermatol Peru, 2011; 21 (2): 70-75.

  6. Guiglia R, Di Liberto C, Pizzo G, Picone L, Lo Muzio L, Gallo P et al. A combined treatment regimen for desquamative gingivitis in patients with oral lichen planus. J Oral Pathol Med. 2007; 36 (2): 110-116.

  7. Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet. 2019; 394: 882-894.

  8. Glickman I, Smulow J. Chronic desquamative gingivitis — its nature and treatment. J Periodontol. 1964; 35 (5): 397-405.

  9. Leuci S, Ruoppo E, Adamo D, Calabria E, Mignogna M. Oral autoimmune vesicobullous diseases: Classification, clinical presentations, molecular mechanisms, diagnostic algorithms, and management. Periodontol 2000. 2019; 80 (1): 77-88.

  10. Williams D. Vesiculo-bullous mucocutaneous disease: benign mucous membrane and bullous pemphigoid. J Oral Pathol Med. 1990; 19 (1): 16-23.

  11. Merritt AH. Chronic desquamative gingivitis. J Periodontol. 1933; 4 (1): 30-34.

  12. Scopp IW. Desquamative gingivitis. J Periodontol. 1964; 35 (2): 149-154.

  13. Almaz ME, Sonmez IŞ. Ozone therapy in the management and prevention of caries. J Formos Med Assoc. 2015; 114 (1): 3-11.

  14. Peralta R, Vázquez F, Portilla J, Carrasco N, Donohué A, Cuevas J et al. Terapia con ozono como posible tratamiento de enfermedad periodontal. Rev Mex Periodontol. 2016; 7 (3): 84-92.

  15. Di Mauro R, Cantarella G, Bernardini R, Di Rosa M, Barbagallo I, Distefano A et al. The biochemical and pharmacological properties of ozone: the smell of protection in acute and chronic diseases. Int J Mol Sci. 2019; 20 (3): 634.

  16. Huth KC, Quirling M, Lenzke S, Paschos E, Kamereck K, Brand K. Effectiveness of ozone against periodontal pathogenic microorganisms. Eur J Oral Sci. 2011; 119 (3): 204-210.

  17. Schwartz A, Martinez G. Potential use of ozone in SARS-CoV-2/COVID-19. Covid19-evidence.paho.org. [Internet]. 2020 [cited 5 December 2020]; 1-18. Available in: https://covid19-evidence.paho.org/handle/20.500.12663/1128?show=full&locale-attribute=pt_BR

  18. Canarias I. El Ozono como desinfectante frente al SARS-CoV-2. INSST [Internet]. 2020 [citado el 5 de diciembre de 2020]; 1-12. Disponible en: https://issuu.com/icaselcanarias/docs/el_ozono_como_desinfectante_frente_al_sars-cov-2__

  19. Kridin K. Pemphigus group: overview, epidemiology, mortality, and comorbidities. Immunol Res. 2018; 66 (2): 255-270.

  20. Discepoli N, Bascones Martínez A. Enfermedad de la mucosa oral: penfigoide de las membranas mucosas. Av Odontoestomatol. 2009; 25 (2): 59-66.

  21. Jiménez Y, Díaz J. Enfermedades ampollares en la cavidad oral: pénfigo. RCOE. 2004; 9 (4): 439-447.




2020     |     www.medigraphic.com